Iconocast Logo

Welcome To Iconocast

How to add a URL link from your web site to the Iconocast web sites

Virtual tour of Southern California



 

Recent News and Articles on the Keywords: measures + antibiotics + performance  Related to the article below (Last Update: 8/5/2008)

National Quality Forum Endorses National Consensus Standards ...
MarketWatch -
Additionally, prophylactic antibiotic measures previously endorsed by NQF were updated to include foot and ankle procedures. Darrell Campell, MD, professor ...
Peripheral Arterial Disease: Diagnosis and Management
RedOrbit, TX -
Some commonly used drugs that interfere with the metabolism of cilostazol include the "azole" class of antifungals, macrolide antibiotics, ...
Not Sold on Performance Measures
Annals of Internal Medicine - Jul 14, 2008
Indeed, one measure (β-blocker use after a myocardial infarction) has been retired because performance has approached perfection (1). ...
A Healthy Conversation Annals of Family Medicine
all 2 news articles »
Cubist Pharmaceuticals Reports First $100 Million Revenue Quarter ...
WELT ONLINE, Germany - Jul 17, 2008
Cubist developed and commercialized CUBICIN? (daptomycin for injection), a Gram-positive first-in-class lipopeptide antibiotic. In the US, Cubist also ...CBST - DYAX
Neogen Reports Record Fourth Quarter and Year-End Results
MarketWatch - Jul 22, 2008
The Russell 2000 Index measures the performance of the small-cap segment of the domestic equity universe, and includes approximately 10% of all publicly ...NEOG
Hospital bungles to be exposed
The Canberra Times, Australia - Jul 22, 2008
The federal minister, Nicola Roxon, said national agreement on 40 performance indicators to measure federal and state health services were "vital, ...
bioMerieux: First-Half 2008 Review
WELT ONLINE, Germany - Jul 22, 2008
By enabling clinicians to make faster and more relevant antibiotic therapy decisions, these tests reduce hospital mortality and the costs associated with ...EPA:BIM - OTC:BDEV
Gilead Sciences, Inc. Q2 2008 Earnings Call Transcript
Seeking Alpha, NY - Jul 31, 2008
On the respiratory front, aztreonam lysine for inhalation is Gilead's unique drug formulation specifically designed to achieve high lung antibiotic ...GILD
Cell Count and Differential of Aspirated Fluid in the Diagnosis of ...
Journal of Bone and Joint Surgery (subscription) - Aug 1, 2008
A thorough chart and database review was performed for all patients to determine antibiotic intake, preoperative serology levels, the results of culture of ...
Advanced Life Sciences Announces Collaboration With UK Ministry of ...
MarketWatch - Jul 17, 2008
The Company's lead candidate, cethromycin, is a novel once-a-day oral antibiotic in late-stage development for the treatment of respiratory tract infections ...ADLS
Source: Google News

The Association between Emergency Department Crowding and Hospital Performance on Antibiotic Timing … -
JM Pines, JE Hollander, AR Localio, JP Metlay - Academic Emergency Medicine, 2006 - Blackwell Synergy
... on mandatory reported performance measures in 2004, specifically 1) the per- centage
of patients admitted with pneumonia who received antibiotics in four hours ...

Quality of care, process, and outcomes in elderly patients with pneumonia -
TP Meehan, MJ Fine, HM Krumholz, JD Scinto, DH … - JAMA, 1997 - Am Med Assoc
... CONCLUSIONS: Administering antibiotics within 8 hours of hospital arrival and ... that
states varied widely in the performance of these measures suggests that ...

Hospitals collaborate to decrease surgical site infections -
EP Dellinger, SM Hausmann, DW Bratzler, RM Johnson … - The American Journal of Surgery, 2005 - Elsevier
... hospitals achieved significant improvement in this measure, which may have had the ...
for administration of the prophylactic antibiotic; performance improved when ...

A statewide initiative to improve the care of hospitalized pneumonia patients: the Connecticut … -
TP Meehan, SR Weingarten, ES Holmboe, D Mathur, Y … - The American Journal of Medicine, 2001 - Elsevier
... Interventions included feedback of performance data (Qualidigm, the ... Process and
outcome measures included early antibiotic administration, blood ...

All-or-None Measurement Raises the Bar on Performance -
T Nolan, DM Berwick - JAMA, 2006 - Am Med Assoc
... of Healthcare Organizations' standard set for pneumonia measures performance with
respect to ... cessation counseling, and mean time to initiation of antibiotics. ...

Change in the Quality of Care Delivered to Medicare Beneficiaries, 1998-1999 to 2000-2001 -
SF Jencks, ED Huff, T Cuerdon - JAMA, 2003 - Am Med Assoc
... Maximizing appropriate antibiotic prophylaxis for surgical patients: an update for ...
Hospital Care National Performance Measures (Group 1)?Interim report, 2002 ...

Effects of the Dietary Inclusion of Copper and (or) Antibiotics on the Performance of Weanling Pigs -
TS Stahly, GL Cromwell, HJ Monegue - Journal of Animal Science, 1980 - Am Soc Animal Sci
... in comparison to the corresponding measures for pigs ... of supple- mental copper and
antibiotics resulted in in ... SUPPLEMENTATION ON THE POSTWEANING PERFORMANCE OF 28 ...

… With Pneumonia: Is it Reasonable to Expect All Patients to Receive Antibiotics Within 4 Hours? -
ML Metersky, TA Sweeney, MB Getzow, F Siddiqui, W … - Chest, 2006 - Am Coll Chest Phys
... implications for regulatory agencies and payers that use the timing of the initial
administration of antibiotics as a pneumonia performance measure, with an ...

The Role of" Colonization Pressure" in the Spread of Vancomycin-Resistant Enterococci An Important … -
MJM Bonten, S Slaughter, AW Ambergen, MK Hayden, J … - Archives of Internal Medicine, 1998 - Am Med Assoc
... with surveillance and control measures now rather ... prevent the spread of antibiotic
resistance? ... Performance Standards for Antimicrobial Disk Susceptibility Tests ...

How do you measure the impact of an antibiotic policy? -
D Nathwani - Journal of Hospital Infection, 1999 - Elsevier
... D. Nathwani Table I How do we measure the performance of antibiotic policies? ... S267
Table II How do we measure the performance of antibiotic policies? ...

Source: Google Scholar

Performance Measures May Lead to Overuse of Antibiotics

Elderly patients hospitalized for suspected pneumonia may be getting antibiotics before their doctor is certain about the diagnosis, a new study suggests.

Among health-care professionals, the practice is known as "shoot first and ask questions later." And the premature use of antibiotics for elderly patients with suspected pneumonia is often done to meet federal performance standards that dictate giving the drugs within four hours of arrival at a hospital.

"Some patients are probably getting antibiotics inappropriately in an attempt to deliver antibiotics quickly to meet externally mandated standards," said lead study author Dr. Mark L. Metersky, a professor of medicine at the University of Connecticut School of Medicine.

The result can lead to increases in antibiotic resistance, unwanted side effects from the drugs, and difficulty identifying the underlying medical problem, the researchers said.

The findings are published in the July issue of the journal Chest.

Metersky's team reviewed the charts of 86 Medicare patients who had ultimately received a diagnosis of pneumonia. Three reviewers evaluated each case to determine how often patients arrived at a hospital with symptoms that weren't typical of pneumonia, calling into question whether the diagnosis was actually pneumonia -- and the course of treatment.

Overall, the researchers found that 22 percent of the patients -- 19 -- had factors suggesting a delay in antibiotic treatment, because there was uncertainty about the diagnosis. Of those patients -- 13, or 68 percent -- received antibiotic treatment within four hours of hospital admission, even though their physician wasn't sure about the diagnosis.

Administering antibiotics within four hours is based on medical evidence that "patients who receive antibiotics within four hours survive at a higher rate than those who don't," Metersky said. "Four hours has been set as the benchmark. But it may take more than four hours in some patients to determine whether they have pneumonia or not."

The study suggests that quality of care may be suffering as hospitals strive to meet standards of care that can determine reimbursements from Medicare and other health plans, Metersky said.

"Every hospital is striving for 100 percent and, ultimately, will be paid by [its] performance, by Medicare and other insurance companies," Metersky said. But, he added, his study found that 22 percent of patients arrive at hospitals without the usual symptoms of pneumonia, making it difficult to determine the diagnosis.

For hospital officials and those who establish standards of care, the message is that "100 percent [antibiotic adherence within four hours] is not an appropriate goal, because it leads to inappropriate care," Metersky said.

"Seventy-five or 80 percent is probably more appropriate," he said.

Metersky said patients should ask their doctor for a diagnosis before agreeing to antibiotic therapy.

Dr. Peter Houck is clinical assistant professor of epidemiology at the University of Washington School of Public Health and Community Medicine, and former director of the Centers for Medicare and Medicaid Services National Pneumonia Project and the Surgical Infection Prevention Project. In an accompanying editorial in the journal, he discussed the seriousness of pneumonia, especially among the elderly. He noted that the disease accounts for more than 750,000 hospitalizations of Americans 65 and older each year, with a death rate of 7 percent while in the hospital and 12 percent within 30 days.

The new study, he said, points to the need for those who establish quality-improvement programs to consider how the measures are being applied, and whether 100 percent is the ideal goal in this case.

In an interview, Houck elaborated on the issue. "Research has shown that if you are over 65, and you have pneumonia severe enough to be hospitalized, your chances of survival are better if you receive your antibiotic sooner rather than later," he said. "If you have pneumonia, you want to receive antibiotics. If you don't, say it is something else, you don't want the antibiotic."

Another expert, Dr. Henry Chambers, chief of infectious diseases at San Francisco General Hospital, said "the methodology [used for the study] is somewhat limited because it is based on chart reviews." Still, he said, the study demonstrates what can happen if too much emphasis is placed on standards over quality of individual patient care. "You start taking care of performance measures, and you don't take care of patients," he said.

Chambers agreed that, in this case, the 100 percent goal is unrealistic. "Anything set at 100 percent encourages gaming the system," he added.

More information

To learn more about pneumonia, visit the American Lung Association.

Spinal Fluid Protein Could Predict Alzheimer's

Measuring levels of a protein in the cerebrospinal fluid of middle-aged adults at high genetic risk for Alzheimer's disease may reveal early signs of disease development, U.S. researchers report.

A team from the University of Washington, Seattle, noted that aging, plus the presence of a copy of a gene called apolipoprotein E*4 (APOE*4) are the two strongest known risk factors for Alzheimer's. People with APOE*4 develop clinical dementia about 10 to 15 years earlier than people without this particular allele (copy).

Previous research had found that Alzheimer's-related plaques in the brain begin forming years before a person shows any symptoms of the disease. These plaques are made of proteins called beta-amyloids, predominately a type known as "A beta 42." As these proteins clump together into plaques, there are fewer circulating through the nervous system.

According to the researchers, this means that lower levels of A beta 42 in the cerebrospinal fluid surrounding the brain and spinal cord are an indicator of the development of Alzheimer's disease.

The study, published in the July Archives of Neurology, included 184 adults, average age 50 years, who had no symptoms of Alzheimer's disease. Researchers checked each participant for the APOE*4 allele and took samples of cerebrospinal fluid to check their levels of A beta 42.

People who were older and had the APOE*4 allele were more likely to have lower levels of A beta 42 than people without the APOE*4 allele. The researchers concluded that people with the APOE*4 allele experienced a slight decline in A beta 42 in their younger years and then a dramatic decline between 50 and 60 years old.

Those without the APOE*4 allele have a slight increase in A beta 42 levels until age 50, and then experience a gradual decline in those levels.

"In persons with the APOE*4 allele, decline in cerebrospinal fluid A beta 42 concentration possibly begins in young adulthood, followed by marked acceleration of this decline beginning in midlife-decades before clinical manifestation of Alzheimer's disease," the study authors wrote.

"These findings have implications for the preclinical diagnosis of Alzheimer's disease, as well as for treatment," they added. "Therapeutic strategies aimed at prevention of Alzheimer's disease may need to be applied in early midlife or even younger ages to have maximal effect on amyloid deposition. Primary prevention trials for Alzheimer's disease targeting elderly persons may [already] be too late to affect the early stages of disease pathology."

More information

The U.S. National Institute on Aging has more about Alzheimer's disease.

 
 
Google
Web www.iconocast.com

Search inside Iconocast for the keyword you have in mind.

Iconocast has collected more than 50,000 articles and press releases on health and science.

These are current and most up to date press releases on the subject you are searching.

We collect current health and science press releases daily from more than 5000 research and health institutes. Here is an example : The elderberry way to perfect skin

We believe if you do search inside Iconocast, you will get better results than searching the web alone.

 
 
Continue News With: News5 ; News6 ; News7 ; News8 ; News9 ; News9A


ADVERTISEMENT

Iconocast is about learning and teaching without borders; we offer eMarketing, Internet Advertising, Internet Marketing, Search Engine Optimization, Search Engine Marketing, Online Branding, and eMarketing News Services.

 

Iconocast Home Page

Contact Iconocast

© 2003-07. ICONOCAST is a trademark of iconocast.com.